Does Rallies show Form 4 insider transactions for EXEL?

Yes. Rallies tracks EXEL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is EXEL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EXEL. It does not provide personalized investment advice.

EXEL (Exelixis) Stock Analysis - Insider Trades

Exelixis (EXEL) is a publicly traded Healthcare sector company. As of May 21, 2026, EXEL trades at $49.31 with a market cap of $12.53B and a P/E ratio of 27.62. EXEL moved +2.56% today. Year to date, EXEL is +17.69%; over the trailing twelve months it is +12.49%. Its 52-week range spans $25.17 to $51.63. Analyst consensus is buy with an average price target of $47.70. Rallies surfaces EXEL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading EXEL stock inside the company?

Recent EXEL insider activity includes Senner Christopher J. sold 34.90K, Hefti Brenda sold 6.63K, Beckerle Mary C sold 7.71K, Freire Maria C sold 20.63K, and POSTE GEORGE sold 60.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

EXEL Key Metrics

Key financial metrics for EXEL
Metric	Value
Price	$49.31
Market Cap	$12.53B
P/E Ratio	27.62
EPS	$1.80
Dividend Yield	0.00%
52-Week High	$51.63
52-Week Low	$25.17
Volume	1.84M
Avg Volume	0
Revenue (TTM)	$2.17B
Net Income	$521.27M
Gross Margin	96.49%

Recent EXEL Insider Trades

Senner Christopher J. sold 34.90K (~$1.75M) on May 18, 2026.
Hefti Brenda sold 6.63K (~$332.64K) on May 18, 2026.
Beckerle Mary C sold 7.71K (~$373.65K) on May 7, 2026.
Freire Maria C sold 20.63K (~$949.16K) on May 7, 2026.
POSTE GEORGE sold 60.00K (~$2.74M) on May 7, 2026.

Latest EXEL News

Exelixis jumps as Q1 EPS beats, $750M new buyback adds support — May 6, 2026
Exelixis slides as RBC trims target to $43 ahead of early-May earnings focus — Apr 24, 2026
Exelixis climbs as pipeline catalysts and 2026 outlook refocus attention on growth — Apr 22, 2026
Exelixis climbs as Barclays lifts price target to $45 ahead of May earnings — Apr 21, 2026
Exelixis slips as insider-sale headlines resurface ahead of May earnings — Apr 15, 2026

EXEL Analyst Consensus

11 analysts cover EXEL: 0 strong buy, 5 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.70.

Common questions about EXEL

Who is trading EXEL stock inside the company?: Recent EXEL insider activity includes Senner Christopher J. sold 34.90K, Hefti Brenda sold 6.63K, Beckerle Mary C sold 7.71K, Freire Maria C sold 20.63K, and POSTE GEORGE sold 60.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for EXEL?: Yes. Rallies tracks EXEL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is EXEL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EXEL. It does not provide personalized investment advice.